Q4 2021 Holdings
Filed 2022-02-14 | 159 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $235.9M | 5,552,300 | 22.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $144.7M | 1,068,800 | 13.9% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $126.0M | 6,073,850 | 12.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $90.8M | 3,196,876 | 8.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $76.1M | 860,880 | 7.3% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $68.6M | 21,642,975 | 6.6% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $59.8M | 4,180,768 | 5.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $55.2M | 230,200 | 5.3% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $36.2M | 4,983,500 | 3.5% |
| Cytek Biosciences Inc(CTKB) | COM | 23285D109 | $31.4M | 1,923,139 | 3.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $16.7M | 6,943,654 | 1.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $15.7M | 406,100 | 1.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $14.3M | 985,900 | 1.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $13.9M | 3,214,509 | 1.3% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $12.4M | 805,041 | 1.2% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $9.0M | 2,648,386 | 0.9% |
| Cvrx Inc(CVRX) | COM | 126638105 | $8.8M | 723,055 | 0.9% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $4.9M | 307,047 | 0.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $4.5M | 207,600 | 0.4% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $3.1M | 127,600 | 0.3% |
| Adagene Inc(ADAG) | ADS | 005329107 | $2.1M | 263,176 | 0.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.1M | 302,509 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $373.6K | 6,028,307 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $270.6K | 4,339,800 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $269.4K | 2,500,055 | 0.0% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $213.5K | 16,838,668 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $213.1K | 13,944,680 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $209.2K | 1,426,400 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $169.3K | 7,330,423 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $154.4K | 2,615,400 | 0.0% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $148.7K | 11,895,652 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $147.6K | 318,300 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $144.5K | 658,100 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $139.4K | 1,076,200 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $136.4K | 1,779,300 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $136.1K | 271,000 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $134.3K | 373,800 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $132.1K | 1,413,985 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $130.3K | 7,447,141 | 0.0% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $125.0K | 10,039,691 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $124.4K | 465,300 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $122.8K | 1,227,400 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $121.0K | 6,337,700 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $113.0K | 1,009,700 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $101.4K | 655,600 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $100.5K | 2,106,450 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $100.1K | 389,500 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $98.3K | 10,280,947 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $98.3K | 1,679,417 | 0.0% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $88.5K | 3,727,466 | 0.0% |